Back to trial details

Intake questionnaire

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Applying to Children's Hospital of Philadelphia · Philadelphia, Pennsylvania

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 18 and 65 years old?
2. Have you been diagnosed with Systemic Lupus Erythematosus?
3. Are you able to travel to Philadelphia for study visits?